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Nephrin in experimental glomerular disease. codes a putative transmembrane protein with eight im-
Background. The recently identified gene NPHS1 with its mu- munoglobulin-like modules and a fibronectin-like extra-
tations causing congenital nephrotic syndrome of the Finnish cellular domain [1]. The FINmajor mutation results in antype (CNF) is highly promising in providing new understanding
early stop codon at exon 2 and causes a failure to expressof pathophysiology of proteinuria. Earlier we cloned a rat
the whole molecule, whereas FINminor causes a nonsenseNPHS1 homologue, as well as characterized and raised anti-
bodies to the respective protein product nephrin. mutation in exon 26 in the intracellular part of nephrin
Methods. Changes in the expression levels of nephrin-specific [1]. We and others have shown that nephrin protein
mRNA in commonly used experimental models of proteinuria localizes at the slit diaphragm and appears to be a majorwere examined using semiquantitative reverse transcription-
functional component of the glomerular filtration barrierpolymerase chain reaction, immunofluorescence, and immu-
noelectron microscopy (IEM) of nephrin. [3, 4].
Results. Notably, a 40% down-regulation of the nephrin-spe- Experimental disease models have remained in wide
cific mRNA of cortical kidney was seen already at day 3 after usage to study various aspects of pathophysiology and
induction of the puromycin aminonucleoside nephrosis (PAN),
structural–functional relationships in the kidney. A fewwhile no major elevation of urinary protein secretion was seen
experimental models are particularly useful in obtainingat this stage. A further decrease of 80% of nephrin message
was seen at the peak of proteinuria at day 10. A similar decrease data that are otherwise not accessible. Puromycin amino-
of up to 70% from the basal levels was seen in mercuric chlo- nucleoside nephrosis (PAN) of the rat morphologically
ride-treated rats. Changes in the protein expression paralleled and functionally resembles human minimal change ne-those of the mRNA in indirect immunofluorescence. Interest-
phrosis [5, 6]. It can be induced with a single injectioningly, a remarkable plasmalemmal dislocation from the normal
of the aminonucleoside of puromycin or with repeatedexpression site at the interpodocyte filtration slits could be
observed in IEM. injections, resulting in slightly different outcomes. After
Conclusions. Nephrin appears to be an important causative single injection, proteinuria develops by day 4 and in-
molecule of proteinuria and shows a remarkable redistribution
creases to its maximum at around day 10. The morpho-from the filtration slits to the podocyte plasma membrane, es-
logic changes in PAN include fusion and retraction ofpecially in PAN.
the foot processes of the glomerular visceral epithelial
cells, podocytes. These are the general morphologic fea-
tures shared by a variety of diseases with proteinuriaA recent article about the novel human gene NPHS1
[7, 8]. Similarly, the classic Heymann nephritis of theand its protein product nephrin explains the basic defect
rat has been a widely used model of immune complex-in the human model disease of proteinuria, congenital
mediated glomerular damage, as seen in membranousnephrotic syndrome of the Finnish type (CNF) [1]. Two
preferential mutations, FINmajor and FINminor, appear to glomerulonephritis [9]. In addition to the rat models,
describe more than 90% of CNF cases in Finland, while knockout and transgenic models in the mouse are in-
a variety of point mutations along the coding region creasingly used to study the role of target molecules of
constituting 29 exons has been reported [2]. NPHS1 en- interest. However, many of the experimental models
used for the rat appear to be difficult or impossible to
induce in the mouse for reasons that are not yet com-Key words: proteinuria, glomerulonephritis, experimental models, slit
diaphragm, lipid peroxidation. pletely clear.
In an earlier study, we cloned the rat nephrin homo-Received for publication January 4, 2000
logue and showed its expression within rat kidney glo-and in revised form April 4, 2000
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Table 1. Experimental designs used in this study
Treatment
PAN1HgCl2 1probucol N 210 days 21 day 0 day 3 days 6 days 9 days 10 days
A PAN 313 U PAN † (N53) U U U † (N53)
B PAN1HgCl2 313 U HgCl2 PAN † (N53) U U U † (N53)
C PAN1HgCl2 1probucol 313 prob U HgCl2 PAN † (N53) U U U † (N53)
D HgCl2 313 U HgCl2 † (N53) U U U † (N53)
E Probucol 313 prob U † (N53) U U U † (N53)
F Controls 313 U saline † (N53) U U U † (N53)
Treatment
Heymann nephritis1
NO inhibition N 0 4 weeks 12 weeks
A Control 10 †
B Nephritis 14 BB BB †
C L-NAME 10 L-NAME L-NAME †
D Nephritis1L-NAME 14 BB 1 BB 1 †
L-NAME L-NAME
Abbreviations are: PAN, aminonucleoside of puromycin; HgCl2, mercuric chloride; prob, probucol; BB, purified brush border antigen; L-NAME, L-NG-nitroarginine-
methylester; †, sacrifice; U, urine samples. For dosages see text.
as the respective protein localization in immunohisto- duced as described previously [11]. Briefly, rats were
divided into four groups (Table 1): (1) controls, (2) Hey-chemistry and immunoelectron microscopy in the widely
used experimental models of glomerular diseases of the mann nephritis, (3) L-NAME (L-NG-nitroarginine-meth-
ylester), and (4) Heymann nephritis–L-NAME. Hey-rat. The results show profound regulation of nephrin,
especially in early PAN nephrosis, and suggest a direct mann nephritis was induced with purified rat kidney
brush border (BB) antigen with two booster immuniza-relationship of nephrin to proteinuria.
tions. L-NAME was given in the drinking water (10
mg/100 mL). Animals were sacrificed at 12 weeks after
METHODS
immunization.
Animal experiments In both experimental groups, samples of cortical kid-
ney tissue were taken after sacrifice for immunofluores-Young male rats of Sprague-Dawley strain (N 5 84)
weighing 250 to 280 g (Department of Bacteriology and cence and immunoelectron microscopic (at day 6 after
verified proteinuria) studies as described earlier [12].Immunology, University of Helsinki, Helsinki, Finland)
were divided into two experimental settings (Table 1). The rest of the cortical tissues were sectioned and snap
frozen in liquid nitrogen and were stored at 2708C untilRats in experiment PAN 1 HgCl2 1 probucol (N 5 36,
further divided into six subgroups) were given a single used.
intraperitoneal injection of puromycin (puromycin amino-
RNA isolationnucleoside 15 mg/100 g; Sigma Chemicals, St. Louis, MO,
USA) and/or mercuric chloride (HgCl2 0.5 mg/100 g; Cortical kidney RNA was isolated either immediately
after sacrifice or from the frozen pieces of tissue (50 toSigma Chemicals) with or without prior daily probucol
(Sigma Chemicals) treatment for 10 days before puromy- 150 mg) with the single-step acid guanidium thiocyanate-
phenol-chloroform procedure using Trizolt reagent (Lifecin/HgCl2 injection. Probucol was given in the animal’s
diet (2% wt/wt) mixed in the pellets, and the consump- Technologies, GIBCO BRL, Paisley, UK) according to
the manufacturer’s instructions [13, 14]. For the removaltion was recorded daily. The control group received 0.9%
saline intraperitoneally in equal amounts at day 0 of puro- of genomic DNA, the RNAs obtained were incubated
with RNase free DNase I (Promega, Madison, WI, USA)mycin injection. Otherwise, the animals were fed with
standard rat chow and had free access to tap water. Urine for 30 minutes in 378C together with human placental
RNase inhibitor (Promega).was collected using metabolic cages at days 0, 3, 6, and 9.
All PAN-treated animals developed albuminuria, which
Semiquantitative reverse transcription-polymerasewas measured by nephelometry (Behring Nephelometer
chain reaction100 analyzer; Behringwerke, Marburg, Germany). From
every group, three animals were sacrificed at days 3 and Since Northern blotting was not sensitive enough for
the detection of nephrin transcripts, we used semiquanti-10, as indicated in Table 1. Tissue samples for immuno-
electron microscopy were also taken at day 7. tative reverse transcription-polymerase chain reaction
(RT-PCR) to determine the differences in transcript lev-Autoimmune Heymann nephritis and its modification
with inhibition of nitric oxide (NO) synthase were in- els in the experimental groups as described [12]. Briefly,
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the 10 mg DNase-treated RNA was reverse transcribed with lead citrate [12]. For quantitations, the gold particles
were counted from photographs, particularly for slit mem-in the presence of oligo dT15-primer (Boehringer Mann-
heim), an RNase inhibitor, and the Moloney murine leu- brane/plasmalemmal localization in the models studied.
kemia virus reverse transcriptase (M-MLV RT) enzyme
Statistical analysis(Promega). cDNAs were diluted 1:5 to 1:3125 to find the
linear range of PCR reactions. The dilutions of 1:125 to Nephrin mRNA quantitations are expressed as mean 6
SD. The Mann–Whitney U-test was used to evaluate the1:3125 were used in equalizing the amounts of cDNA
according to the b-actin levels [12, 15]. Sequence-specific differences between mean values. A P value , 0.05 was
considered significant.oligonucleotide primers were designed according to rat
nephrin sequence. Primers that included all of the splic-
ing variants (RN-S3, upper 59-agcctcttgaccatcgctaa and
RESULTS
lower RN-AS3, 59-cccagtcagcgtgaaggtag) corresponding
Urinary albuminto nucleotides 2692 to 2994 were used. For semiquantita-
tion of nephrin, the dilutions of 1:5 to 1:125 were used. Animals treated with puromycin started to develop al-
buminuria at day 3, reaching maximum at day 9, as shownPolymerase chain reaction (PCR) reactions were per-
formed (total volume 25 mL) in the presence of 0.5 in Figure 1. With the dosage of HgCl2 used, urinary albu-
min remained close to that of the controls and did notmmol/L each of the specific oligonucleotide primers, 0.2
mmol/L dNTP (Finnzymes, Espoo, Finland), 10 3 PCR exceed 1.5 mg/day. Also, the rats receiving probucol
alone did not show increased albuminuria. In all of thebuffer (Perkin Elmer, Norwalk, CT, USA), and 1 U
AmpliTaq polymerase (Perkin-Elmer Cetus). The am- puromycin-treated rats, however, urinary albumin started
to increase at day 3, irrespective of the combinatoryplification program started with an initial denaturation at
948C for three minutes and continued with annealing at treatment, and the albumin levels increased constantly
by day 6 and peaked at day 9. In Heymann nephritis at568C for one minute and 728C for 45 seconds, followed
by 28 cycles (b-actin primers) or 30 cycles (nephrin prim- 12 weeks, experimental nephritis albuminuria was less
than 10 mg/day, and the most significant albuminuriaers) at 948C for 45 seconds, 568C for one minute, and
728C for 45 seconds. was detected in the nephritis-L-NAME group (less than
20 mg/day) [11].
Immunohistochemistry
RT-PCRTissues for light and electron microscopy were taken
instantly at sacrifice as described earlier [12, 16]. The fro- To detect the expression level of rat nephrin mRNA
in experimental models, we used semiquantitative RT-zen tissue sections were cut at 3 mm, were acetone fixed
at 2208C for 10 minutes, and were incubated with the PCR, as Northern blotting was not sensitive enough. For
this purpose, we chose the nucleotides (2692 to 2994) nearrespective affinity-purified polyclonal antibody [1:50 dilu-
tion in phosphate-buffered saline (PBS)] against the intra- the transmembrane area. In puromycin nephritis, a 40%
down-regulation at postinjection day 3 (P 5 0.037) andcellular nephrin domain (aa 1101 to 1126). The secondary
antibody was fluorescein isothiocyanate (FITC)-conju- an 80% down-regulation at day 10 (P 5 0.027) were ob-
served as compared with the respective levels in the con-gated rat anti-rabbit IgG (Dako, Glostrup, Denmark).
For an approach to semiquantitate nephrin protein ex- trols (Fig. 2). After the HgCl2 treatment, a closely similar
pattern with rapid decrease of nephrin mRNA level atpression in kidney tissue, a dilution series of the first
antibody (1:50, 1:200, 1:500, 1:1000 in PBS) was applied day 3 was seen, whereas pretreatment with probucol re-
sulted in a mild 1.4- and 1.35-fold increase at days 3 andon the sections on the same glass slide and the consensus
end point of specific fluorescence as recorded by two 10, respectively (Fig. 3). In the group combining PAN and
HgCl2 treatments, an even more pronounced drop in theindependent observers using arbitrary scale of 2 (nega-
tive), 1 (faint positive), 11 (positive), and 111 (strong nephrin level was observed as early as day 3.
positive), respectively.
Immunohistochemistry
Immunoelectron microscopy Antibodies against the intracellular domain of nephrin
showed a typical patchy epithelial-like reactivity withinImmunoelectron microscopy was done essentially as
described earlier [17]. Fixation was done for six hours glomeruli in the normal kidneys (Fig. 4A). An altered
pattern of reactivity was seen in the PAN-treated group:at 208C followed by embedding in Lowicryl K4M (Chem-
ische Werke LOWI, Waldkraiburg, Germany). Ultrathin a more patchy and less intense (from 11 to 1) reactivity
was seen (Fig. 4A) in the 10-day samples, whereas negli-sections were blocked with 1% ovalbumin in PBS for one
hour, followed by incubation with affinity-purified rabbit gible changes were seen at day 3. Only a slight change in
the Heymann nephritis (Fig. 4B) and HgCl2 groups wasantinephrin antibodies (50 mg/mL) and an anti-rabbit 10
nm gold conjugate (1:50). Sections were counterstained seen (Fig. 4D). This decrease in the semiquantitation of
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Fig. 1. Daily urine albumin excretion levels in the experimental groups (Table 1). Symbols are: (h) day 1; ( ) day 3; ( ) day 6; (j) day 9.
Fig. 2. Electrophoretic analysis of reverse
transcription-polymerase chain reaction (RT-
PCR) products from puromycin aminonucleo-
side nephrosis (PAN), PAN 1 HgCl2, and
PAN 1 HgCl2 1 probucol groups 10 days
after disease induction. cDNA dilutions used
are normalized to the respective b-actin RT-
PCR products. The quantitative results are
shown in Figure 3.
nephrin expression in tissues detected by end-point titra- of the filtration slits (Fig. 5), while practically no gold
particles were seen outside of podocytes. However, espe-tion was verified by two independent observers (Table 2).
cially in the diseased glomerulus, single gold particles
Immunoelectron microscopy were regularly observed along the apical plasma mem-
brane of podocytes, while even in these situations, mostIn postembedding immunoelectron microscopy, the
anti-intracellular nephrin antibodies distinctly labeled the of the label was observed at the filtration slits (Fig. 6).
To quantitate these changes, the immunogold particlesinterpodocyte areas of normal rat glomeruli at the level
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Fig. 3. Time-dependent nephrin transcript levels
of the cortical kidney in the experimental settings,
as determined by RT-PCR. Symbols are: ( ) 3
days; (j) 10 days; *P , 0.05, †P . 0.05 vs. mean
of the control.
Fig. 4. Immunofluorescence of nephrin ex-
pression in normal (A), Heymann nephritis
(B), PAN (C), and mercuric chloride (D)-
treated rat kidney. The less intense reactivity
in B, C, and D is obvious (3360).
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Table 2. Semiquantitation of nephrin protein expression in different localization at the slit membrane. Whether this displace-
animal models studied by end-point titration
ment from the filtration slit is due to a preferential ex-
Dilution Control HN PAN 10 days HgCl2 PAN1HgCl2 pression of a specific splicing variant is being studied in
1:50 111 111 1 111 1 detail. Examples of similar soluble truncated forms of
1:200 111 11 1 111 1 other transmembrane molecules modulating the disease
1:500 11 1 6 11 6
phenotype have been reported, for example, for angio-1:1000 1 6 2 2 2
tensin-converting enzyme [20].The intensity of nephrin immunofluorescense reactivity within glomeruli was
graded (from 2, negative to 111, strong positive) by two independent observ- Knockout and transgenic mouse models are powerful
ers. Abbreviations are: HN, Heymann nephritis; PAN, puromycin nephritis; tools that are widely applied to renal research. The mouseHgCl2, nephrosis induced by mercuric chloride.
models have proven particularly useful for revealing the
role of molecules in the developing kidney [21]. How-
ever, conflicting results have been repeatedly reported
in the characterization of, for example, the phenotypeswere counted separately from the plasma membrane and
filtration slit areas of podocytes, respectively. Results of of transgenic interferon-g (INF-g) monocyte chemoat-
tractant protein-1 (MCP-1), and CCR-1 mice, apparentlythis quantitation are presented in Table 3.
reflecting variations between strains, housing condition,
and even immunization protocol [22]. In the meantime,
DISCUSSION
the classic rat models, including the nephrotoxic nephri-
The classic and widely used experimental models of pu- tis (a model for acute inflammatory nephritis), aminonu-
romycin and Heymann nephritides with their modifica- cleoside nephrosis (a model for minimal change), and
tions proved useful to reveal changes in the expression Heymann nephritis (a model for membranous glomeru-
pattern of nephrin in semiquantitative RT-PCR, immuno- lonephritis) have remained widely used and suitable to
histochemistry, and immunoelectron microscopy in rela- obtain functionally relevant data effectively.
tion to the functional change of proteinuria. The results, Here we found a marked and systematic reduction in
especially with the semiquantitative RT-PCR, show a re- the level of nephrin-specific mRNA down to less than 20%
markable down-regulation of the respective mRNA levels of control values at day 10 of PAN. The onset of mRNA
and give insight into the role of nephrin for glomerular drop is found even before marked albuminuria and is
filtration. suggestive of causality. These findings are supported by
Congenital nephrotic syndrome of the Finnish type similar changes observed by Furness et al in acquired
has been considered as a prototype of single gene disease human nephrotic syndrome [23]. This result indirectly
affecting a basic functional characteristic of glomerular suggests that nephrin is involved in a crucial functional
filtration. Thus, the positional cloning and identification position to control glomerular permselectivity. Similar
of the NPHS1 gene mutated in CNF now offer new tools changes were found in all groups treated with PAN.
for studying the less well-known pathophysiology of pro- Diamond, Bonventre, and Karnovsky showed the forma-
teinuria. However, this requires the full establishment tion of reactive oxygen radicals (ROS) via the enhanced
of the molecular, structural, and biochemical pathways xanthine pathway in PAN nephrosis [24]. Additionally,
in which nephrin is involved. Lenkkeri et al have exten- hypoxanthine, the breakdown product of puromycin, ap-
sively characterized the gene structure and its defects pears to lead directly to the formation of free oxygen
and found a variety of changes (point mutations) along radicals. Furthermore, in vitro studies have revealed that
the whole coding sequence, while the FINmajor and FINminor puromycin has an impact on rat glomerular epithelial
mutations appear dominant in Finnish patients [2]. Al- cells (GECs) via the generation of active oxygen [25, 26].
most 20% of their CNF patients failed to show changes As glomeruli appear sensitive to locally produced reac-
in the coding region [2]. Interestingly, Topham et al very tive oxidants, particularly lipid peroxidation [27], a shift
recently showed that the monoclonal antibody 5-1-6, in the oxidant balance induced by PAN could result in
shown to induce heavy proteinuria in vivo [18] without the drop of nephrin mRNA and subsequent proteinuria.
the morphologic effacement of podocyte foot processes, Probucol, on the other hand, is a molecule that was
recognizes the extracellular domain of nephrin [19]. Our initially developed for lipid lowering and it effectively
recent results have provided evidence of a unique splic- prevents lipid peroxidation [26]. In our study, the admin-
ing of the nephrin-specific mRNA [3]. Together, these istration of probucol alone appeared to increase the level
results suggest a complex mechanism of nephrin gene of nephrin-specific mRNA. Thus, we propose that the
regulation and especially of active post-transcriptional protein complex, including nephrin of the filtration slit,
modifications to maintain an intact permeability barrier. may be particularly vulnerable to lipoperoxidation dam-
Interestingly, our results with immunohistochemistry and age. Alternatively, lipoperoxidation may be particularly
immunoelectron microscopy show nephrin protein at the important for intracellular signaling in podocytes.
Mercuric chloride accumulates to lysosomes and sup-plasma membrane of podocytes in addition to its major
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Fig. 5. Postembedding immunoelectron microscopy of normal rat kidney glomerulus. Distinct localization of nephrin at the filtration slit area is
seen (A and B). (C) Gold particles are also seen at the apical plasma membrane. SD, slit diaphragm (335,000).
Table 3. Distribution of immunogold particles in the podocyte in
the models studied
Particles (counted) Controls HN 6 days PAN 7 days
Total 211 (100%) 71 (100%) 69 (100%)
Surface 57 (27%) 19 (27%) 60 (87%)
Slit diaphragm 154 (73%) 52 (73%) 9 (13%)
Total number and number of particles in podocyte plasmalemma and slit dia-
phragm are indicated.
mimic membranous nephropathy [9]. We found only a
20% drop in nephrin mRNA level in Heymann nephritis
rats. Inducing Heymann nephritis together with a nitric
oxide synthase (NOS) inhibitor failed to cause apprecia-
ble changes in the nephrin mRNA level. However, the
Fig. 6. In a sample from Heymann nephritic kidney, nephrin remains samples for Heymann nephritis and NO inhibition exper-
abundant at the filtration slit area, while gold particles are also found in
iments were taken considerably later, at 12 weeks fromintracellular vacuoles (V) and at the surface of podocytes. Abbreviations
are: ID, immune deposit; GBM, glomerular basement membrane (mag- the induction of disease. Thus, the possible initial dam-
nification 335,000). age as seen in PAN nephritis may have been missed. On
the other hand, the method for mRNA quantitation used
may be considered semiquantitative, and thus, the 20%
presses the rate of adenosine 59-triphosphate (ATP) syn- decrease seen in Heymann nephritis may be artificially
thesis of mitochondria. Mercuric chloride also causes too low. Earlier time points for mRNA quantitations
acute renal damage [28, 29]. Given the fact that most may thus be needed. Together, these results suggest that
lipoperoxides are derived from the mitochondria, it was nephrin may be preferentially involved in diseases/mod-
of interest to test the combined effect of PAN and HgCl2, els acutely involving the structural–functional relation-
particularly in combination with probucol. When mercu- ships of the filtration slits.
ric chloride was added to the PAN model, an even more
In conclusion, this study demonstrates significantrapid drop in nephrin mRNA was found, while the profile
changes in the mRNA levels of nephrin in PAN nephro-of proteinuria remained unchanged. This may reflect an
sis even prior to proteinuria. Immunohistochemical re-indirect involvement of nephrin in the filtration barrier
sults also show parallel findings for the protein product.via the association with other structural proteins. With
The changes in nephrin levels could be modified remark-the probucol dosage used, the resulting proteinuria in
ably by probucol. As no appreciable changes could bethe PAN/HgCl2 combination could not be prevented. In
demonstrated in the late phases of Heymann nephritis,our previous results [3], however, we failed to show a
our results lead to the following hypothesis: Nephrinclose association of nephrin two key junctional proteins:
is critically involved in the molecular structure of theZO-1 [30] and occludin [31].
Heymann nephritis is the widely used rat model to interpodocyte filtration slit structure, which is regulated
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